- By insider
Chairman, President & CEO of Idexx Laboratories Inc (IDXX) Jonathan W Ayers sold 54,000 shares of IDXX on 01/11/2018 at an average price of $165.98 a share. The total sale was $9 million.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories Inc has a market cap of $14.96 billion; its shares were traded at around $171.51 with a P/E ratio of 55.68 and P/S ratio of 8.09. IDEXX Laboratories Inc had annual average EBITDA growth of 13.50% over the past ten years. GuruFocus rated IDEXX Laboratories Inc the business predictability rank of 5-star.
-
Warning! GuruFocus has detected 8 Warning Signs with F. Click here to check it out.
-
The intrinsic value of IDXX
CEO Recent Trades:
-
Chairman, President & CEO Jonathan W Ayers sold 54,000 shares of IDXX stock on 01/11/2018 at the average price of $165.98. The price of the stock has increased by 3.33% since.
For the complete insider trading history of IDXX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 8 Warning Signs with F. Click here to check it out.
-
The intrinsic value of IDXX